The role of cell cycle‐mediated events in Alzheimer's disease

The mechanism(s) underlying selective neuronal death in Alzheimer's disease remain unresolved. However, recently, we and others showed that susceptible hippocampal neurones in Alzheimer's disease express markers common to cells in various phases of the cell cycle. Since neuronal maturation is associated with effective escape from the cell division cycle, emergence out of quiescence may be deleterious. Here, we review a number of current findings indicating that disregulated ectopic re‐activation of cell cycle‐mediated events, akin to neoplasia, represent an important early pathway associated with neuronal death and, more importantly, one that involves virtually the entire spectrum of the pathological events described in Alzheimer's disease.

[1]  M. Smith,et al.  Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease. , 1999, Medical hypotheses.

[2]  Mark A. Smith,et al.  Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli , 1999, Brain Research.

[3]  David S. Park,et al.  Cyclin-dependent Kinases Participate in Death of Neurons Evoked by DNA-damaging Agents , 1998, The Journal of cell biology.

[4]  Hans Clevers,et al.  Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis , 1998, Nature.

[5]  G. Evan,et al.  A matter of life and cell death. , 1998, Science.

[6]  Mark A. Smith,et al.  VULNERABLE NEURONS IN ALZHEIMER DISEASE ACCUMULATE MITOCHONDRIAL DNA WITH THE COMMON 5KB DELETION , 1998 .

[7]  K. Hirai,et al.  ACCUMULATION OF 8-HYDROXY-GUANOSINE IN NEURONAL CYTOPLASM INDICATES MITOCHONDRIAL DAMAGE AND RADICAL PRODUCTION ARE EARLY FEATURES OF ALZHEIMER DISEASE , 1998 .

[8]  J. Palacino,et al.  Regulation of Apoptosis by Presenilin 1 , 1998, Neurobiology of Aging.

[9]  N. Robakis,et al.  Alzheimer's disease: a re-examination of the amyloid hypothesis , 1998, Trends in Neurosciences.

[10]  M. Mattson,et al.  Presenilins, the Endoplasmic Reticulum, and Neuronal Apoptosis in Alzheimer's Disease , 1998, Journal of neurochemistry.

[11]  T. Arendt,et al.  Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease , 1998, Journal of Neural Transmission.

[12]  S. Janicki,et al.  Increased Apoptosis Arising from Increased Expression of the Alzheimer's Disease–associated Presenilin-2 Mutation (N141I) , 1997, The Journal of cell biology.

[13]  Jinhe Li,et al.  Alzheimer Presenilins in the Nuclear Membrane, Interphase Kinetochores, and Centrosomes Suggest a Role in Chromosome Segregation , 1997, Cell.

[14]  S. Singer,et al.  Cell surface expression of the Alzheimer disease-related presenilin proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Smith,et al.  Cell cycle markers in the hippocampus in Alzheimer’s disease , 1997, Acta Neuropathologica.

[16]  M. Smith,et al.  Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. , 1997, The American journal of pathology.

[17]  M. Mattson,et al.  Alzheimer’s Presenilin Mutation Sensitizes Neural Cells to Apoptosis Induced by Trophic Factor Withdrawal and Amyloid β-Peptide: Involvement of Calcium and Oxyradicals , 1997, The Journal of Neuroscience.

[18]  S. Tonegawa,et al.  Skeletal and CNS Defects in Presenilin-1-Deficient Mice , 1997, Cell.

[19]  D. Price,et al.  Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm , 1997, Nature.

[20]  G. Jicha,et al.  Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer’s Disease Brain , 1997, The Journal of Neuroscience.

[21]  John Hardy,et al.  Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.

[22]  Joseph S. Beckman,et al.  Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease , 1997, The Journal of Neuroscience.

[23]  A. Smith,et al.  Expression of cell division markers in the hippocampus in Alzheimer’s disease and other neurodegenerative conditions , 1997, Acta Neuropathologica.

[24]  P. Greengard,et al.  The Cytoplasmic Domain of Alzheimer’s Amyloid Precursor Protein Is Phosphorylated at Thr654, Ser655, and Thr668 in Adult Rat Brain and Cultured Cells , 1997, Molecular medicine.

[25]  M. Sousa,et al.  Developmental changes in calcium content of ultrastructurally distinct subcellular compartments of preimplantation human embryos. , 1997, Molecular human reproduction.

[26]  M. Mattson,et al.  Alzheimer's PS‐1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β‐peptide , 1996, Neuroreport.

[27]  P. Vito,et al.  Requirement of the Familial Alzheimer's Disease Gene PS2 for Apoptosis , 1996, The Journal of Biological Chemistry.

[28]  Stephen J. Elledge,et al.  Cell Cycle Checkpoints: Preventing an Identity Crisis , 1996, Science.

[29]  T. Sunderland,et al.  Participation of Presenilin 2 in Apoptosis: Enhanced Basal Activity Conferred by an Alzheimer Mutation , 1996, Science.

[30]  G. Hannon,et al.  Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  U. Gärtner,et al.  Expression of the cyclin‐dependent kinase inhibitor p16 in Alzheimer's disease , 1996, Neuroreport.

[32]  C. Cotman,et al.  Alzheimer‐associated presenilin‐2 confers increased sensitivity to poptosis in PC12 cells , 1996, FEBS letters.

[33]  M. Smith,et al.  Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease , 1996, Brain Research.

[34]  D. Selkoe,et al.  Amyloid β-Protein and the Genetics of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.

[35]  M. Beal,et al.  Oxidative damage in Alzheimer's , 1996, Nature.

[36]  S. Takeda,et al.  G Protein-Mediated Neuronal DNA Fragmentation Induced by Familial Alzheimer's Disease-Associated Mutants of APP , 1996, Science.

[37]  P. Pippia,et al.  Static cytofluorometry and fluorescence morphology of mitochondria and DNA in proliferating fibroblasts. , 1996, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[38]  B. Hyman,et al.  Alzheimer–associated presenilins 1 and 2 : Neuronal expression in brain and localization to intracellular membranes in mammalian cells , 1996, Nature Medicine.

[39]  P. Davies,et al.  Mitotic mechanisms in Alzheimer's disease? , 1996, The Journal of cell biology.

[40]  P. Vito,et al.  Interfering with Apoptosis: Ca2+-Binding Protein ALG-2 and Alzheimer's Disease Gene ALG-3 , 1996, Science.

[41]  M. Smith,et al.  Evidence for oxidative stress in Pick disease and corticobasal degeneration , 1995, Brain Research.

[42]  Iva Greenwald,et al.  Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene , 1995, Nature.

[43]  R N Kalaria,et al.  Induction of Heme Oxygenase‐1 mRNA and Protein in Neocortex and Cerebral Vessels in Alzheimer's Disease , 1995, Journal of neurochemistry.

[44]  T. Arendt,et al.  Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease , 1995, Neuroscience.

[45]  R. Heumann,et al.  Induction of p21ras in Alzheimer pathology. , 1995, Neuroreport.

[46]  C. Lippa,et al.  Ki‐67 Immunoreactivity in Alzheimer's Disease and Other Neurodegenerative Disorders , 1995, Journal of neuropathology and experimental neurology.

[47]  M. Nitta,et al.  Nuclear Accumulation of p53 in Normal Human Fibroblasts Is Induced by Various Cellular Stresses which Evoke the Heat Shock Response, Independently of the Cell Cycle , 1995, Japanese journal of cancer research : Gann.

[48]  G. Ferrari,et al.  N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[49]  M. Smith,et al.  Advanced Maillard reaction end products are associated with Alzheimer disease pathology , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[50]  G. Evan,et al.  Apoptosis and the cell cycle. , 1995, Current opinion in cell biology.

[51]  J. Brion,et al.  Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons , 1994, Neuroscience.

[52]  B. Stewart.  Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. , 1994, Journal of the National Cancer Institute.

[53]  G. Perry,et al.  Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. , 1994, The American journal of pathology.

[54]  P. Greengard,et al.  Cell cycle‐dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. , 1994, The EMBO journal.

[55]  S. Estus,et al.  Analysis of cell cycle-related gene expression in postmitotic neurons: Selective induction of cyclin D1 during programmed cell death , 1994, Neuron.

[56]  E. Mandelkow,et al.  Abnormal Alzheimer‐like phosphorylation of tau‐protein by cyclin‐dependent kinases cdk2 and cdk5 , 1993, FEBS letters.

[57]  John Q. Trojanowski,et al.  Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule binding , 1993, Neuron.

[58]  H. Yeh,et al.  Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[59]  J. Ávila,et al.  Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease , 1992, FEBS letters.

[60]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[61]  Brian J Cummings,et al.  Induction of basic fibroblast growth factor in Alzheimer's disease pathology. , 1990, Neuroreport.